Hancock Whitney Corp Buys Shares of 13,142 HealthEquity, Inc. (NASDAQ:HQY)

Hancock Whitney Corp acquired a new position in shares of HealthEquity, Inc. (NASDAQ:HQY) in the 1st quarter, Holdings Channel.com reports. The fund acquired 13,142 shares of the company’s stock, valued at approximately $1,073,000.

Several other large investors also recently made changes to their positions in HQY. Cape Investment Advisory Inc. acquired a new position in HealthEquity during the fourth quarter worth $27,000. Rise Advisors LLC acquired a new position in HealthEquity during the first quarter worth $28,000. YHB Investment Advisors Inc. acquired a new position in HealthEquity during the first quarter worth $40,000. Fidelis Capital Partners LLC acquired a new position in HealthEquity during the first quarter worth $42,000. Finally, Parallel Advisors LLC boosted its holdings in HealthEquity by 255.5% during the fourth quarter. Parallel Advisors LLC now owns 679 shares of the company’s stock worth $45,000 after purchasing an additional 488 shares during the last quarter. Institutional investors own 99.55% of the company’s stock.

Analyst Ratings Changes

Several research analysts recently commented on HQY shares. Robert W. Baird increased their target price on shares of HealthEquity from $98.00 to $104.00 and gave the stock an “outperform” rating in a report on Tuesday, June 4th. KeyCorp increased their price target on shares of HealthEquity from $95.00 to $100.00 and gave the company an “overweight” rating in a research note on Wednesday, June 5th. Barrington Research increased their price target on shares of HealthEquity from $100.00 to $105.00 and gave the company an “outperform” rating in a research note on Tuesday, June 4th. Royal Bank of Canada reiterated an “outperform” rating and issued a $92.00 price target on shares of HealthEquity in a research note on Tuesday, June 4th. Finally, Bank of America reiterated a “buy” rating and issued a $105.00 price target on shares of HealthEquity in a research note on Wednesday, July 3rd. One equities research analyst has rated the stock with a hold rating and twelve have given a buy rating to the company. According to data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $101.67.

HealthEquity Price Performance

HQY stock traded down $6.81 during mid-day trading on Friday, hitting $71.06. The stock had a trading volume of 274,563 shares, compared to its average volume of 619,521. The company has a current ratio of 4.39, a quick ratio of 4.39 and a debt-to-equity ratio of 0.44. HealthEquity, Inc. has a 52 week low of $61.81 and a 52 week high of $88.26. The firm has a market capitalization of $6.18 billion, a P/E ratio of 77.46, a P/E/G ratio of 1.32 and a beta of 0.57. The firm has a fifty day simple moving average of $81.42 and a 200 day simple moving average of $80.13.

HealthEquity (NASDAQ:HQY) last released its earnings results on Monday, June 3rd. The company reported $0.55 EPS for the quarter, beating the consensus estimate of $0.47 by $0.08. HealthEquity had a net margin of 7.71% and a return on equity of 7.77%. The firm had revenue of $287.60 million for the quarter, compared to analyst estimates of $278.78 million. As a group, research analysts forecast that HealthEquity, Inc. will post 2.12 EPS for the current year.

Insider Activity

In other news, Vice Chairman Stephen Neeleman sold 2,080 shares of the firm’s stock in a transaction that occurred on Friday, June 7th. The shares were sold at an average price of $85.01, for a total value of $176,820.80. Following the sale, the insider now directly owns 90,515 shares in the company, valued at approximately $7,694,680.15. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. In related news, Vice Chairman Stephen Neeleman sold 2,080 shares of HealthEquity stock in a transaction that occurred on Friday, June 7th. The shares were sold at an average price of $85.01, for a total transaction of $176,820.80. Following the sale, the insider now directly owns 90,515 shares in the company, valued at approximately $7,694,680.15. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. Also, CEO Jon Kessler sold 32,326 shares of the business’s stock in a transaction that occurred on Monday, June 24th. The stock was sold at an average price of $82.83, for a total transaction of $2,677,562.58. Following the completion of the transaction, the chief executive officer now owns 232,176 shares in the company, valued at approximately $19,231,138.08. The disclosure for this sale can be found here. In the last three months, insiders have sold 77,511 shares of company stock worth $6,314,446. Corporate insiders own 2.20% of the company’s stock.

HealthEquity Company Profile

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.